A comparison of Measles-Rubella-Zoster Reaction, Oligoclonal IgG Bands, Oligoclonal Kappa Free Light Chains and Kappa Index in Multiple Sclerosis

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction

(2023) Benjamin Vlad et al.   Frontiers in Neurology

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement

(2022) Harald Hegen et al.   Multiple Sclerosis Journal

Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure

(2021) Carmen Teresa Sanz Diaz et al.   Frontiers in Neurology

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis

(2020) Tilman Robinson et al.   Cells

The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis

(2018) Tilman Hottenrott et al.   BMC Neurology

The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis

(2018) Tilman Hottenrott et al.   JOURNAL OF NEUROLOGY

Low intrathecal antibody production despite high seroprevalence of Epstein–Barr virus in multiple sclerosis: a review of the literature

(2017) Klemens Ruprecht et al.   JOURNAL OF NEUROLOGY

An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis

(2016) Matteo Gastaldi et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature

(2016) S. Jarius et al.   JOURNAL OF NEUROLOGY

Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesis

(2013) Fabio Duranti et al.   JOURNAL OF NEUROIMMUNOLOGY

Intrathecal oligoclonal IgG synthesis in multiple sclerosis

(2013) Axel Petzold   JOURNAL OF NEUROIMMUNOLOGY

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

(2013) Charlotte Teunissen et al.   Multiple Sclerosis Journal